, Tracking Stock Market Picks
Enter Symbol:

down 73.02 %

MEDIVATION INC (MDVN) rated Buy with price target $180 by Canaccord Genuity

Posted on: Wednesday,  Apr 8, 2015  9:25 AM ET by Canaccord Genuity

Canaccord Genuity rated Buy MEDIVATION INC (NASDAQ: MDVN) on 04/08/2015, when the stock price was $129.60. Since then, MEDIVATION INC
has lost 73.02% of its value until Canaccord Genuity rated MDVN Hold on 01/27/2016, when the price was $34.96.
If you would have followed this Canaccord Genuity's recommendation on MDVN, you would have lost 73.02% of your investment in 294 days.

Medivation, Inc. is a biopharmaceutical company with small molecule drugs in clinical development to treat three medical needs: Alzheimer?s disease, Huntington?s disease and castration-resistant prostate cancer. The Company has formed separate subsidiaries to hold the product candidates it is developing. The Company?s subsidiary Medivation Neurology, Inc. holds its Dimebon technology, and its subsidiary Medivation Prostate Therapeutics, Inc. holds its MDV300 series technology.

Canaccord Genuity’s global team of over 100 research professionals are inquisitive, experienced and committed to generating actionable investment ideas. We analyze over 725 companies in a broad range of market sectors, identifying value and defining risk for our clients.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/27/2016 9:25 AM Hold
34.96 45.00
as of 8/27/2015
1 Week down  -10.35 %
1 Month down  -20.67 %
3 Months down  -25.37 %
1 YTD down  -28.95 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/8/2015 9:25 AM Buy
129.60 180.00
9/18/2014 9:25 AM Buy
99.80 132.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy